{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:01:05Z","timestamp":1794916865768,"version":"4.9.1"},"reference-count":31,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL 150237"],"award-info":[{"award-number":["K23 HL 150237"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NIGMS","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The defining radiological features of autoimmune interstitial lung disease (ILD) are ground glass opacification (GGO) and fibrosis. The associations between these features and physiological response to immunomodulation remain unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This study leveraged three autoimmune ILD cohorts: two with systemic sclerosis (SSc) and one with rheumatoid arthritis (RA) which were selected for inherent differences in fibrotic extents\/patterns. Linear regression models examined associations between baseline quantitative GGO, fibrosis, their ratio and forced vital capacity (FVC)%-predicted changes after 12 months of immunomodulatory therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Patients with SSc-ILD (N=262) exhibited a higher GGO-to-fibrosis ratio compared with patients with RA-ILD (N=130) (mean ratio 3.0 vs 0.25). Increased GGO-to-fibrosis was not associated with improved FVC%-predicted in any cohort. Conversely, in patients with SSc-ILD treated with cyclophosphamide (CYC), increased fibrosis (estimate 0.17 (95% CI 0.003, 0.33); p=0.04) and increased GGO (estimate 0.15 (95% CI 0.004, 0.30); p=0.044) were both significantly associated with FVC% improvement. Given the negative direction of the estimate for GGO-to-fibrosis ratio (estimate -0.33 (95% CI -0.61, \ufffd0.06); p=0.016), CYC was associated with greater FVC% improvement in patients with a higher degree of fibrosis relative to GGO. No significant correlation was seen in patients with SSc-ILD treated with mycophenolate (N=56) or in patients with RA-ILD treated with immunomodulation (N=130).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Increased quantitative GGO relative to fibrosis was not significantly associated with improved response to immunomodulation in patients with RA-ILD and SSc-ILD. However, increased quantitative fibrosis and GGO extent were associated with improved response to CYC in SSc-ILD. More research is needed to understand how to use radiological features to guide treatment selection in ILD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/thorax-2024-222367","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:45:16Z","timestamp":1744292716000},"page":"540-546","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts"],"prefix":"10.1136","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-9597","authenticated-orcid":false,"given":"Scott M","family":"Matson","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, The University of Kansas School of Medicine, Kansas City, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Hyun J","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-4530","authenticated-orcid":false,"given":"Stephen M","family":"Humphries","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Jewish Health, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences Research, University of California, Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-9947","authenticated-orcid":false,"given":"Jonathan","family":"Goldin","sequence":"additional","affiliation":[{"name":"Department of Radiologic Sciences, University of California, Los Angeles, Los Angeles, California, USA"},{"name":"UCLA Health, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-4872","authenticated-orcid":false,"given":"Donald P","family":"Tashkin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Internal Medicine and Health Sciences Research, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant R","family":"England","sequence":"additional","affiliation":[{"name":"Medicine, Division of Rheumatology & Immunology, University of Nebraska Medical Center, Omaha, NE USA and Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, USA, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-6569","authenticated-orcid":false,"given":"Elizabeth R","family":"Volkmann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2025071508200871000_80.8.540.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0053"},{"key":"2025071508200871000_80.8.540.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.002"},{"key":"2025071508200871000_80.8.540.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC"},{"key":"2025071508200871000_80.8.540.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0444"},{"key":"2025071508200871000_80.8.540.5","doi-asserted-by":"crossref","unstructured":"Humphries SM , Adegunsoye A , Demoruelle MK , et al . Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest 2024. doi:10.1016\/j.chest.2024.10.052","DOI":"10.1016\/j.chest.2024.10.052"},{"key":"2025071508200871000_80.8.540.6","doi-asserted-by":"crossref","DOI":"10.4081\/mrm.2023.890","article-title":"Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease","volume":"18","author":"Dsouza","year":"2023","journal-title":"Multidiscip Respir Med"},{"key":"2025071508200871000_80.8.540.7","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-2-146"},{"key":"2025071508200871000_80.8.540.8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review","volume":"9","author":"Laria","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025071508200871000_80.8.540.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2022.03.005"},{"key":"2025071508200871000_80.8.540.10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173806","article-title":"Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)","volume":"10","author":"Yamakawa","year":"2021","journal-title":"J Clin Med"},{"key":"2025071508200871000_80.8.540.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.30438"},{"key":"2025071508200871000_80.8.540.12","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2023","article-title":"Towards the adoption of quantitative computed tomography in the management of interstitial lung disease","volume":"33","author":"Walsh","year":"2024","journal-title":"Eur Respir Rev"},{"key":"2025071508200871000_80.8.540.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"2025071508200871000_80.8.540.14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30152-7"},{"key":"2025071508200871000_80.8.540.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.11.035"},{"key":"2025071508200871000_80.8.540.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2223-2"},{"key":"2025071508200871000_80.8.540.17","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017161177"},{"key":"2025071508200871000_80.8.540.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.11.033"},{"key":"2025071508200871000_80.8.540.19","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14333"},{"key":"2025071508200871000_80.8.540.20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.517"},{"key":"2025071508200871000_80.8.540.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2098-2"},{"key":"2025071508200871000_80.8.540.22","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12234"},{"key":"2025071508200871000_80.8.540.23","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1442170"},{"key":"2025071508200871000_80.8.540.24","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13175"},{"key":"2025071508200871000_80.8.540.25","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2251011555"},{"key":"2025071508200871000_80.8.540.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00117-010-2070-1"},{"key":"2025071508200871000_80.8.540.27","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.9.738"},{"key":"2025071508200871000_80.8.540.28","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.189.3.8234692"},{"key":"2025071508200871000_80.8.540.29","article-title":"Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study","volume":"54(suppl 63)","author":"Mittal","year":"2019","journal-title":"Eur Respir J"},{"key":"2025071508200871000_80.8.540.30","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201802-079OC"},{"key":"2025071508200871000_80.8.540.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30318-0"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:25:36Z","timestamp":1753179936000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,15]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/thorax-2024-222367"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222367","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}